The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Filter
Locations
Result types
Type of company
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Lock keywords
Exclude keywords
Optional keywords
Prague, Czechia
11-50 Employees
2005
We are thrilled to announce that Bionano Symposium 2024 – a pinnacle event for the genomics community will take place 22.-25.
+
Featured
Optical Genome Mapping
... Optical Genome Mapping All genome structural variants are no more an issue with advanced optical genome mapping (OGM) platform by Bionano. ...
Providence, United States
11-50 Employees
2004
Founded in 2005, Nabsys emerged as the very first life science company to call Rhode Island its home. The story of Nabsys began with a merger of two small startups rooted within the Brown University ecosystem. At its core, Nabsys is the torchbearer of electronic genome mapping using solid-state nanodetection, a groundbreaking technology with applications in DNA analysis. Nabsys harnessed the potential of solid-state nanodetectors, ushering in an era where single DNA molecules are meticulously analyzed to reveal both their location and identity over vast stretches, introducing a new technology to view genomes as whole using long-range genomic data. Nabsys was honored to be the recipient of the prestigious “$1,000 Genome” award from the National Human Genome Research Institute, a testament to our electronic approach to DNA sequencing. Today, Nabsys stands at the threshold of a new era in genomics with the introduction of the OhmX platform. Nabsys’s technology can detect structural variants ranging from approximately 300bp in size to large chromosomal rearrangements with read lengths over 100kb. Nabsys currently boasts 17 patent families, a testament to our pioneering spirit and dedication to advancing genomics.
+
Featured
Whole-Genome Mapping Using Electronic Detection
... Whole-Genome Mapping Using Electronic ...
Cape Town, South Africa
11-50 Employees
1988
Whitehead Scientific is a leading provider of quality life science consumables and instrumentation. Empowering scientists with solutions from an extensive product range. Whitehead Scientific is a proud supplier of leading international brands. Whitehead Scientific was founded in 1988 and remains privately owned. Whitehead Scientific is a well-established, full service channel partner representing a range of leading international suppliers of life science solutions. Whitehead Scientific is dedicated to ensuring an advanced level of product quality, technical support, along with expertise and attention to customer service. Explore our portfolio of industry leading international brands.
+
Featured
BioNano Genomics Saphyr Optical Genome Mapping Instrument
... BioNano Genomics Saphyr Optical Genome Mapping ...
Montevideo, Uruguay
1-10 Employees
2021
Kinzbio won the NOVA Award in the StartUp category for its contributions to the field of antimicrobial research. Specifically recognized for their pioneering work in "Jumbo Phages for the Development of New Anti-bacterial Tools and Other Biomedical Applications.". The NOVA Awards by ANII aim to celebrate impactful initiatives, foster an innovative culture across diverse sectors, and highlight success stories that underscore Uruguay's capacity for innovation. This acknowledgment serves as motivation, inspiring us to persist in our innovative pursuits for a better world.
+
Featured
Microbial Solutions | Kinzbio
... Microbial Genome Mapping ...
San Diego, United States
101-250 Employees
2003
We are committed to being present for our customers along their journeys, providing the guidance and support they need to reach their destinations. Let’s explore what Bionano solutions can do for you. At Bionano, we strive to elevate health and wellness for all people through customer-centered innovations that transform the way the world sees the genome. Bionano optical genome mapping (OGM) solutions address this critical gap. Bionano OGM solutions provide the essential tools clinicians and researchers need to reveal actionable insights from all classes of genomic variation. Together, we are moving health and hope forward for patients and their families forward. Bionano's VIA is the only analysis software that receives and interprets data from optical genome mapping (OGM), next-generation sequencing (NGS) and microarrays to contextualize all classes of genomic variation and drive meaningful insights. Together with our customers, we are embarking on a journey to a new view of the genome and human health.
+
Featured
Bionano: Transforming the Way the World Sees the Genome
... Bionano Genomics to acquire Purigen Biosystems to enable further simplified and accelerated DNA isolation for optical genome mapping (OGM) and address difficult sample types in new applications with isotachophoresis (ITP) on the Iconic purification system. ...
Beverly, United States
11-50 Employees
2005
Our mission is to provide new systems to streamline and improve sample preparation workflows for DNA and protein analysis. Sage Science develops products for the life sciences research markets. It is headquartered and manufactures at 500 Cummings Center in Beverly, MA, USA. Here's a rundown of scientific posters from #AGBT23 that featured Sage products.
+
Featured
Pippin Pulse | Sage Science
... Intact DNA purified from flow-sorted nuclei unlocks the potential of next-generation genome mapping and assembly in Solanum ...
Cambridge, United Kingdom
11-50 Employees
Our mission is to unlock the full potential of the human genome’s 3D organisation for target and biomarker discovery. We are backed by Bioqube Ventures, Start Codon, BGF, Parkwalk, and private investors. We are a functional genomics company exploring the 3D organisation of DNA in health and disease.
+
Featured
Technology – Enhanc3D Genomics
... Whole-genome 3D structure mapping ...
Zapopan, Mexico
11-50 Employees
The Genetic Innovation Science Group delivers all CGIAR crop breeding and genebank work with the key aim of accelerating adoption and turnover of improved crop varieties among small-scale farmers in low- and medium- income countries. The interconnected Genetic Innovation Initiatives are at the core of delivering this strategy, by working with partners to:. Seed Equal: Aims to support the delivery of seed of improved, climate-resilient, market-preferred and nutritious varieties of priority crops, embodying a high rate of genetic gain to farmers, ensuring equitable access for women and other disadvantaged groups.
+
Featured
Sorghum mid-density genotyping services | Excellenceinbreeding
... The genome-wide SNPs were called following the whole genome re-sequencing of the sorghum reference panel and can be used for QTL mapping, Genome-Wide Association Studies (GWAS), Genomic Selection, fingerprinting of breeding material, variety tracking and genetic diversity studies. ...
United States
The ADA Forsyth Institute is a top-tier NIH-funded research institute focused on exploring the connections between oral health and overall well-being, with over a century-long legacy of changing the oral health landscape. ADA Forsyth scientists were among those who discovered that fluoride could help prevent cavities. We developed the first local antibiotic to treat gum disease and sequenced the first oral bacterial genome. The current research at Forsyth aims to transform public health. The ADA Forsyth Institute’s mission is to improve oral and overall health through a combination of innovative research and community outreach by accelerating the delivery of wellness solutions locally and globally. William and Jane Forsyth move from Scotland to Boston. James Forsyth dies at the age of 60. John and Thomas Forsyth begin their plans to build a cathedral “dedicated to the children.” To help realize James’ vision, John and Thomas add $1.5 million of their own fortunes to James’ gift.
+
Featured
Home - Forsyth
... New study mapping entire genome of oral stem cells opens new doors for regenerative ...
Lancaster, United Kingdom
11-50 Employees
1987
We are in essence a ‘One Stop Shop.’ As well as warehousing your books in our secure facility, our marketing team produce subject targeted sales material and apply social media as a tool to promote our publishers’ titles. Gazelle Book Services is a book distribution company that offers publishers the opportunity to increase their sales in the UK and throughout Europe. In recent times Lancaster is also well-known for its University, founded in 1964 and one of the top Universities in the country with students attending from around the world. The book distribution business is constantly changing and we are well positioned to adapt to these changes. Continued focus on sourcing personnel that will both compliment and add further value to the Gazelle brand, to actively look to extend our network of sales and to invest in additional channels and new ideas that would benefit us, our publishers and our clients. Receive information on our latest titles and offers.
+
Featured
Handbook of Optimization Theory — Gazelle Book Services Ltd
... Several problems in modern genome mapping analysis belong to the field of discrete optimisation on a set of all possible orders. In this book, formulations, mathematical models and algorithms for genetic/genomic mapping problem that can be formulated in TSP-like terms are proposed. Since the ...
Technologies which have been searched by others and may be interesting for you:
Some interesting numbers and facts about the results you have just received for Genome Mapping
| Country with most fitting companies | United Kingdom |
| Amount of fitting manufacturers | 8 |
| Amount of suitable service providers | 7 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1987 |
| Youngest suiting company | 2021 |
Genome mapping is a scientific technique that determines the location of genes and the distances between genes on a chromosome. This method involves identifying landmarks on the genome, a process akin to creating a navigational chart of an unexplored ocean. These landmarks can be expressed sequences known as genes, or segments of DNA with a known function, and sequences with no known function. The ultimate goal is to establish a complete map of all genes in an organism, providing a framework for navigating the vast genetic landscape. Genome mapping is foundational in the field of genomics, serving as a critical step towards understanding the blueprint of life encoded within an organism's DNA. It plays a pivotal role in identifying genetic markers associated with diseases, which in turn facilitates the development of targeted therapies and personalized medicine. Moreover, genome mapping has revolutionized agriculture by enabling the identification and manipulation of genes responsible for traits such as yield, drought tolerance, and pest resistance. This technique has not only expanded our understanding of genetic inheritance but also opened new avenues for research in evolutionary biology, population genetics, and conservation biology. By laying down the groundwork for further genetic analysis, genome mapping continues to be instrumental in unraveling the complexities of the genome, thereby advancing our capability to harness and manipulate genetic information for the betterment of society.
1. Increased Accuracy in Genetic Research
Genome mapping provides a highly detailed overview of the genetic makeup of an organism. This precision facilitates the identification of genes linked to specific diseases, enabling earlier and more accurate diagnoses compared to traditional methods.
2. Enhanced Personalized Medicine
By understanding an individual's genetic predisposition to certain conditions, genome mapping allows for the development of personalized treatment plans. This tailored approach not only improves patient outcomes but also minimizes the risk of adverse drug reactions.
3. Accelerated Drug Development
The insights gained from genome mapping expedite the process of discovering new drugs. By identifying specific genetic targets, researchers can develop treatments more efficiently, significantly reducing the time and cost associated with bringing new medicines to market.
4. Better Understanding of Evolutionary Relationships
Genome mapping sheds light on the evolutionary history of species by comparing genetic sequences. This knowledge enhances our understanding of biodiversity and the mechanisms of evolution, providing valuable insights into the conservation of endangered species.
While evaluating the different suppliers make sure to check the following criteria:
1. Technology Platform
Ensure the supplier uses the latest genome mapping technologies, such as optical mapping or nanopore sequencing, to provide high-resolution and accurate results.
2. Data Analysis Capabilities
Check if the supplier offers comprehensive data analysis tools and software that can help in interpreting the complex data generated from genome mapping.
3. Experience and Expertise
Evaluate the supplier's experience in genome mapping, including the number of projects completed and their expertise in handling various types of genomes.
4. Turnaround Time
Consider the time it takes for the supplier to complete the genome mapping project, ensuring it meets your project timelines.
5. Cost
Compare the cost of services among suppliers, but ensure you're not compromising on the quality of the genome mapping services for lower prices.
6. Customer Support and Communication
Assess the level of customer support provided, including the ease of communication and the supplier's responsiveness to inquiries and updates regarding the project.
Genome mapping has become a cornerstone in the agricultural sector, enabling companies to enhance crop yields and resistance to pests and diseases. By understanding the genetic markers associated with desirable traits, businesses can develop high-performing crop varieties more rapidly, ensuring food security and sustainability. In the pharmaceutical and biotechnology industries, genome mapping is pivotal for drug discovery and personalized medicine. It allows companies to identify genetic sequences linked to specific diseases, leading to the development of targeted therapies. This precision medicine approach not only streamlines research and development but also offers patients more effective and tailored treatment options. The environmental sector benefits from genome mapping through biodiversity conservation and ecosystem management. By analyzing the genetic diversity of species, businesses can implement more informed conservation strategies, helping to protect endangered species and restore ecological balance. Lastly, in animal breeding, genome mapping facilitates the selection of traits such as disease resistance, productivity, and temperament, leading to healthier and more productive livestock. This technology supports the sustainability and profitability of the animal husbandry industry, ensuring high-quality meat, dairy, and other animal products. These use cases illustrate the versatility of genome mapping across various industries, highlighting its role in driving innovation, efficiency, and sustainability in business-to-business applications.
Genome mapping has reached a high Technology Readiness Level (TRL), specifically between TRL 7 to 8, where the technology has demonstrated its functionality in relevant environments and is on the cusp of final testing and validation. This advancement is primarily due to significant technical breakthroughs in sequencing technologies and bioinformatics analysis. High-throughput sequencing methods, such as Next-Generation Sequencing (NGS), have dramatically reduced the cost and time required to sequence DNA, making genome mapping more accessible and practical for a wide range of applications. Furthermore, the development of sophisticated bioinformatics tools has enabled the efficient analysis and interpretation of complex genomic data, paving the way for precise mapping of genetic material. These tools can identify genetic markers, variations, and relationships that were previously undetectable, offering unprecedented insights into the genetic blueprint of organisms. The current TRL reflects the robustness of genome mapping technologies, which have been rigorously tested in various settings, including clinical trials, agricultural biotechnology, and evolutionary biology research. The ongoing optimization of sequencing chemistries and data analysis algorithms continues to enhance the accuracy, speed, and affordability of genome mapping, solidifying its status as a mature and reliable technology in the field of genomics.
In the short-term, genome mapping is set to benefit significantly from advancements in sequencing technologies and computational biology. These improvements will lead to faster, more accurate genome mapping at lower costs. Immediate impacts include enhanced genetic screening for diseases and personalized medicine, where treatments can be tailored to an individual's genetic makeup. Innovations in CRISPR technology are also making precise gene editing more accessible, promising immediate applications in agriculture and disease resistance. Looking into the mid-term, the integration of artificial intelligence and machine learning with genome mapping will revolutionize our understanding of complex genetic interactions. This period will likely see the development of predictive models that can forecast genetic predispositions to diseases long before symptoms appear. The ability to analyze vast genetic datasets in real-time will also accelerate the discovery of new therapeutic targets, paving the way for groundbreaking treatments and preventative measures. This phase is crucial for the transition from reactive to proactive healthcare. In the long-term, genome mapping is expected to achieve unprecedented levels of precision and personalization. Technologies like nanopore sequencing could democratize genome mapping, making it a routine part of healthcare and wellness monitoring. We may see the advent of truly personalized medicine, where every treatment and preventive measure is optimized for an individual's unique genetic profile. This era will likely witness the full realization of gene therapy's potential, correcting genetic disorders at their source and significantly extending human healthspan and quality of life.
